PlainRecalls
FDA Devices Moderate Class II Terminated

Dimension Vista Assays: Direct HDL Cholesterol (AHDL)

Reported: May 18, 2016 Initiated: March 17, 2016 #Z-1663-2016

Product Description

Dimension Vista Assays: Direct HDL Cholesterol (AHDL)

Reason for Recall

Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may occur on samples drawn from patients receiving N-Acetylcysteine (NAC) or Metamizole. NAC is the accepted antidote for acetaminophen toxicity and is justified in patients at signific

Details

Units Affected
137422 units total
Distribution
Nationwide: AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, Puerto Rico, St. Thomas, VI, Guam, Pacific Mariana Islands
Location
Newark, DE

Frequently Asked Questions

What product was recalled?
Dimension Vista Assays: Direct HDL Cholesterol (AHDL). Recalled by Siemens Healthcare Diagnostics, Inc.. Units affected: 137422 units total.
Why was this product recalled?
Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may occur on samples drawn from patients receiving N-Acetylcysteine (NAC) or Metamizole. NAC is the accepted antidote for acetaminophen toxicity and is justified in patients at signific
Which agency issued this recall?
This recall was issued by the FDA Devices on May 18, 2016. Severity: Moderate. Recall number: Z-1663-2016.